8 Results for "

RPN1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "RPN1" in MCE Product Catalog:

Cat. No.: HY-RS12210
Research Areas:  

Others

RPN1 Human Pre-designed siRNA Set A contains three designed siRNAs for RPN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26845
Research Areas:  

Others

Rpn1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Rpn1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20337
Research Areas:  

Others

Rpn1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rpn1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-181495
CAS No.: 2375455-53-9
RAJQ14 is a BRD4 PROTAC-like CAP-TAC (Proteasome Cap Targeting Chimeras) degrader. RAJQ14 binds to 19S proteasome cap subunits RPN1, RPN10, RPN13, and USP14 to recruit target proteins to the proteasome for ubiquitination-independent, proteasome-dependent degradation. RAJQ14 can be used for the research of cancer [1] (Pink: BRD4 Ligand (HY-181496); Blue: Proteasome Ligand (HY-128978); Black: Linker).
loading...
    loading...
Cat. No.: HY-P88132
Synonyms: P97; RPN1; S2; TRAP2

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Dog, Rat, Monkey, Mouse

loading...
    loading...
Cat. No.: HY-RS11323
Research Areas:  

Others

PSMD2 Human Pre-designed siRNA Set A contains three designed siRNAs for PSMD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P88132A
Synonyms: P97; RPN1; S2; TRAP2

Host:  

Mouse

Application:  

IHC-P, ICC/IF

Reactivity:  

Human, Dog, Rat, Monkey, Mouse

loading...
    loading...
Cat. No.: HY-181098
CAS No.: 3060515-85-4
FKA-9i is an orally active anticancer agent. FKA-9i directly binds to and promotes the degradation of oncoproteins LRPPRC (kd: 7.387 μM), YBX1 (kd: 16.52 μM) and RPN1 (kd: 26.82 μM). FKA-9i inhibits the MAPK signaling pathway and mitochondrial oxidative phosphorylation. FKA-9i also induces cancer cell cycle arrest, apoptosis, mitochondrial dysfunction and ROS accumulation. FKA-9i can be used in the research of tumors such as gastric cancer [1].
loading...
    loading...